姜黄素纳米给药系统抗耐甲氧西林金黄色葡萄球菌的活性研究
Study on the Anti-Methicillin Resistant Staphylococcus aureus by Curcumin Nanometer Dosing System
DOI: 10.12677/HJCET.2018.83020, PDF,    国家自然科学基金支持
作者: 张逸菲, 吴文超, 吴江青, 吴谢琦, 黄冬雪, 郭钫元, 杨根生*:浙江工业大学药学院,浙江 杭州;谢 捷:杭州市疾病预防控制中心,浙江 杭州
关键词: 耐甲氧西林金黄色葡萄球菌姜黄素纳米粒Methicillin-Resistant Staphylococcus aureus Curcumin Nanoparticles
摘要: 耐甲氧西林金黄色葡萄球菌因其极强的传染性已经成为引起院内感染的重要致病菌之一,首选药物万古霉素近年来不断出现耐药株,这使得MRSA的治疗更加棘手。姜黄素是一种天然来源的抗菌药,在抗耐药性方面有无法比拟的优点。但是姜黄素由于性质不稳定,在水中溶解性差,生物利用度低等缺点限制其临床应用。纳米粒载体能够显著提高姜黄素的水溶性和生物利用度,延长药物在体内的滞留时间并降低药物的毒副作用。本课题通过开环聚合的方法制备PET-CL高聚物为载体材料,采用溶剂挥发法制备姜黄素纳米粒,并对姜黄素纳米粒粒径,PDI,包封率和载药量进行表征。姜黄素PET-CL纳米粒稳定,其体外释放表现出明显缓释特性。此外,姜黄素PET-Cl纳米粒还具有持续的抑菌作用。上述结果可为扩大姜黄素药用范围,丰富其治疗途径和对抗菌活性机制的深入研究提供理论依据。
Abstract: MRSA (methicillin-resistant Staphylococcus aureus) has become one of the major sources of hospital-acquired infections due to the powerful infectivity. Vancomycin, the preferred drug, has been overused, inducing that the vancomycin resistant strains were constantly discovered in recent years, which made the MRSA treatment more difficult. Curcumin (Cur), a natural antiseptic, displays prominent advantages in fighting against antibiotic resistance. However, its broad clinical applicability and effectiveness are limited by aqueous insolubility, low systemic bioavailability, and instability. Nanoparticles (NPs) are efficient carriers to improve the aqueous solubility, bioavailability, the drug circulation time in the blood, and the risk of side effects of curcumin. In this work, we synthesized amphiphilic copolymers (PET-Cl) by ring-opening polymerization; NPs were then prepared via emulsion-solvent evaporation method. Meanwhile, particle size, Zeta potential, entrapment efficiency (EE) and drug-loading (DL) content of Cur nanoparticles were measured. In in vitro release study, Cur PET-Cl nanoparticles were stable, and it showed obvious sustained release characteristics in vitro. In addition, Cur PET-Cl nanoparticles displayed a persistent bacteriostatic effect. These results indicate that the study on Cur PET-Cl nanoparticles can provide theoretical basis for expanding medicinal range, enriching the therapeutic pathway and improving the antibacterial activity mechanism research.
文章引用:张逸菲, 谢捷, 吴文超, 吴江青, 吴谢琦, 黄冬雪, 郭钫元, 杨根生. 姜黄素纳米给药系统抗耐甲氧西林金黄色葡萄球菌的活性研究[J]. 化学工程与技术, 2018, 8(3): 165-173. https://doi.org/10.12677/HJCET.2018.83020

参考文献

[1] [1] 朱玉林, 熊玉玲, 夏小荣, 等. 儿童感染耐甲氧西林葡萄球菌耐药性分析[J]. 江苏医药, 2015(21): 2541-2543.
[2] 卢赞, 尹利民, 刘德华, 等. 昆明某院2005~2013年葡萄球菌种类分布及耐甲氧西林菌株检出率[J]. 国际检验医学杂志, 2015(19): 2828-2830.
[3] 栗艳, 贾艳艳, 孙渊, 等. 耐甲氧西林金黄色葡萄球菌的致病机制及治疗药物研究进展[J]. 中国药师, 2013, 16(3): 441-444.
[4] Gould, I.M., Reilly, J., Bunyan, D., et al. (2010) Costs of Health Care Associated Methicillin-Resistant Staphylococcus aureus and Its Control. Clinical Microbiology & Infection, 16, 1721-1728.
[Google Scholar] [CrossRef] [PubMed]
[5] Klevens, R.M., Morrison, M.A., Nadle, J., et al. (2007) Invasive Methicillin-Resistant Staphylococcus aureus Infections in the United States. Journal of the American Medical Association, 298, 1763-1771.
[Google Scholar] [CrossRef] [PubMed]
[6] Schmitz, G.R. (2011) How Do You Treat an Abscess in the Era of Increased Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA)? Journal of Emergency Medicine, 41, 276.
[Google Scholar] [CrossRef] [PubMed]
[7] Jung, Y.J., Koh, Y., Hong, S.B., et al. (2010) Effect of Vancomycin plus Rifampicin in the Treatment of Nosocomial Methicillin-Resistant Staphylococcus aureus Pneumonia. Critical Care Medicine, 38, 175.
[Google Scholar] [CrossRef
[8] Welte, T. and Pletz, M.W. (2010) Antimicrobial Treatment of Nosocomial Meticillin-Resistant Staphylococcus aureus (MRSA) Pneumonia: Current and Future Options. International Journal of Antimicrobial Agents, 36, 391-400.
[Google Scholar] [CrossRef] [PubMed]
[9] Song, W., Qiao, X., Liang, W.F., et al. (2015) Efficient Separation of Curcumin, Demethoxycurcumin, and Bisdemethoxycurcumin from Turmeric Using Supercritical Fluid Chromatography: From Analytical to Preparative Scale. Journal of Separation Science, 38, 3450-3453.
[Google Scholar] [CrossRef] [PubMed]
[10] Taverna, S., Giallombardo, M., Pucci, M., et al. (2015) Curcumin Inhibits in vitro and in vivo Chronic Myelogenous Leukemia Cells Growth: A Possible Role for Exosomal Disposal of miR-21. Oncotarget, 6, 21918.
[Google Scholar] [CrossRef] [PubMed]
[11] Kaur, H., Patro, I., Tikoo, K., et al. (2015) Curcumin Attenuates Inflammatory Response and Cognitive Deficits in Experimental Model of Chronic Epilepsy. Neurochemistry International, 89, 40-50.
[Google Scholar] [CrossRef] [PubMed]
[12] 张英, 李冬梅, 邢颖. 姜黄素的药理作用与载体研究进展[J]. 中国药房, 2015(13): 1850-1853.
[13] Yallapu, M., Jaggi, M. and Chauhan, S.C. (2012) Curcumin Nanoformulations: A Future Nanomedicine for Cancer. Drug Discovery Today, 17, 71-80.
[Google Scholar] [CrossRef] [PubMed]
[14] NCCLS/CLIS. (2016) Performance Standards for Antimicrobial Susceptibility Testing. 26th Edition.